Archive for January, 2012

• 

  FDA approves Gleevec for expanded use in patients with rare gastrointestinal cancer

  0January 31, 2012
  Confirmatory trials show significantly prolonged survival in patients; drug granted regular approval The U.S. Food and Drug Administration today granted...
• 

  FDA approves Kalydeco to treat rare form of cystic fibrosis

  0January 31, 2012
  Breakthrough therapy targets defective protein The U.S. Food and Drug Administration today approved Kalydeco (ivacaftor) for the treatment of a...
• 

  FDA approves new treatment for most common type of skin cancer

  0January 30, 2012
  Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma,...
• 

  FDA approves Inlyta to treat patients with a type of advanced kidney cancer

  0January 27, 2012
  Drug helps keep cancer from progressing The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with...
• 

  FDA permits marketing of first test for risk of rare brain infection in some people treated with Tysabri

  0January 20, 2012
  Today, the U.S. Food and Drug Administration allowed marketing of the first test to help determine the risk for a...
• 

  FDA approves Voraxaze to treat patients with toxic methotrexate levels

  0January 17, 2012
  Helps lower high blood levels of the chemotherapy drug The U.S. Food and Drug Administration today approved Voraxaze (glucarpidase) to...
• 

  FDA to protect important class of antimicrobial drugs for treating human illness

  0January 4, 2012
  Agency issues order prohibiting certain uses in food-producing animals   The U.S. Food and Drug Administration today issued an order...